Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pericardial mesothelioma.

W T Vigneswaran1, P R Stefanacci

  • 1Loyola University Medical Center Chicago and Stritch School of Medicine, 2160 South First Avenue, Maywood, IL 60153, USA.

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantification of cytomegalovirus (CMV) viral load by the hybrid capture assay allows for early detection of CMV disease in lung transplant recipients.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2001
Same author

Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody.

Transplantation·2001
Same author

Surgical strategy of complex empyema thoracis.

JSLS : Journal of the Society of Laparoendoscopic Surgeons·2000
Same author

Lung transplantation at Loyola University Medical Center.

Clinical transplants·2000
Same author

Electrophysiological and clinical comparison of two temporary pacing leads following cardiac surgery.

Pacing and clinical electrophysiology : PACE·1999
Same author

Elevated coronary endothelin-1 but not nitric oxide in diabetics during CABG.

The Annals of thoracic surgery·1999
Same journal

Interaction between Regulated Cell Death Pathways and Core Cellular Processes: Unraveling the Molecular Mechanisms of Cardiotoxicity of Antitumor Drugs.

Current treatment options in oncology·2026
Same journal

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Current treatment options in oncology·2026
Same journal

Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review.

Current treatment options in oncology·2026
Same journal

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

Current treatment options in oncology·2026
Same journal

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.

Current treatment options in oncology·2026
Same journal

Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research.

Current treatment options in oncology·2026
See all related articles

Primary pericardial mesothelioma is a rare, lethal cancer. Complete surgical removal offers the best chance for long-term survival, though diagnosis is often delayed and treatments are limited.

Area of Science:

  • Oncology
  • Cardiovascular Surgery

Background:

  • Primary pericardial mesothelioma is an exceptionally rare and aggressive malignancy.
  • Fewer than 150 cases are documented in medical literature.
  • Diagnosis is frequently incidental, occurring post-mortem or during surgery.

Purpose of the Study:

  • To review the clinical presentation, diagnostic challenges, and therapeutic strategies for primary pericardial mesothelioma.
  • To highlight the prognostic factors influencing patient outcomes.
  • To explore potential future treatment directions based on advancements in related malignancies.

Main Methods:

  • Literature review of reported cases of primary pericardial mesothelioma.
  • Analysis of clinical signs, symptoms, and diagnostic methods.

Related Experiment Videos

  • Evaluation of surgical and non-surgical treatment outcomes.

    • Main Results:

    • Nonspecific symptoms often mimic other cardiac conditions, delaying diagnosis.
    • Surgical resection is the primary treatment, with long-term survival possible for localized, completely resected tumors.
    • Tumor invasion into cardiac structures frequently renders complete resection impossible, limiting treatment to palliative care.

    Conclusions:

    • Complete surgical resection is crucial for favorable prognoses in primary pericardial mesothelioma.
    • Current adjuvant therapies (chemotherapy, radiation) have shown limited efficacy.
    • Emerging treatments for malignant pleural mesothelioma may offer future therapeutic avenues for pericardial mesothelioma.